Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), three people with ...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
Daily, weekly and monthly curated newsletters on the deal ecosystem in India
Breaking news alerts
Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced